Treatment of pneumonia in patients at risk of infection with gram-negative bacilli

J L McGehee1, S D Podnos, A K Pierce

  • 1Department of Internal Medicine, University of Texas Health Science Center, Southwestern Medical School, Dallas 75235-9034.

Insights

For community-acquired pneumonia patients, broad-spectrum antibiotics can be shortened if they improve quickly. This approach is safe and effective when no specific pathogen is identified.

Area of Science:

  • Infectious Diseases
  • Internal Medicine
  • Pharmacology

Background:

  • Patients with chronic debilitating diseases are susceptible to gram-negative bacilli infections, including community-acquired pneumonia.
  • Empiric broad-spectrum parenteral antibiotics are standard for high-risk pneumonia patients pending culture results.
  • Optimal duration of empiric therapy is unclear when cultures are negative.

Purpose of the Study:

  • To determine the safety and efficacy of abbreviated broad-spectrum parenteral antibiotic therapy in community-acquired pneumonia patients with negative cultures.
  • To evaluate the impact of clinical response on treatment duration and outcomes.

Main Methods:

  • Retrospective chart review of 131 hospitalized patients with community-acquired pneumonia.
  • Patients received broad-spectrum parenteral antibiotics; specific pathogens were not isolated.
  • Analysis of treatment duration and patient outcomes, including cure, complication, and relapse rates.

Main Results:

  • 89% of patients achieved successful outcomes without complications or relapse.
  • Patients treated for four days or less due to rapid clinical improvement had a 95% success rate.
  • Abbreviated therapy was associated with successful outcomes in this cohort.

Conclusions:

  • Broad-spectrum parenteral antibiotic therapy for community-acquired pneumonia can be safely shortened.
  • Prompt clinical improvement is a key indicator for safely abbreviating antibiotic duration.
  • This strategy may help reduce antibiotic exposure and associated risks.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...